1,311
Views
34
CrossRef citations to date
0
Altmetric
Liver and Biliary Disease

Benign recurrent intrahepatic cholestasis: review and long-term follow-up of five cases

, &
Pages 482-488 | Received 06 Jul 2011, Accepted 11 Dec 2011, Published online: 10 Jan 2012

References

  • van der Woerd WL, van Mil SWC, Stapelbroek JM, Klomp LWJ, van de Graaf SFJ, Houwen RHJ. Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy. Best Pract Res Clin Gastroenterol 2010;24:541–53.
  • Summerskill WHJ, Walsh JM. Benign recurrent intrahepatic obstructive jaundice. Lancet 1959;2:686–90.
  • Tygstrup N, Jensen B. Intermittent intrahepatic cholestasis of unknown aetiology in five young males from the Faroe Islands. Acta med Scand 1969;185:523–30.
  • Houwen RH, Baharloo S, Blankenship K, Raeymakers P, Juyn J, Sandkuijl LA, Genome screening by searching for shared segments: mapping of a gene for benign recurrent intrahepatic cholestasis. Nat Genet 1994;8:380–6.
  • Bull LN, van Eijk MJ, Pawlikowska L, DeYoung JA, Juijn JA, Liao M, A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998;18:219–24.
  • Stapelbroek JM, van Erpecum KJ, Klomp LWJ, Houwen RHJ. Liver disease associated with canalicular transport defects: current and future therapies. J Hepatol 2010;52:258–71.
  • Klomp LW, Vargas JC, van Mil SW, Pawlikowska L, Strautnieks SS, van Eijk MJ, Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology 2004;40:27–38.
  • Kubitz R, Keitel V, Haussinger D. Inborn errors of biliary canalicular transport systems. Methods Enzymol 2005;400:558–69.
  • Elferink RPJO, Paulusma CC, Groen AK. Hepatocanalicular transport defects: patophysiologic mechanisms of rare diseases. Gastroenterology 2006;130:908–25.
  • Saich R, Collins P, Ala A, Standish R, Hodgson H. Benign recurrent intrahepatic cholestasis with secondary renal impairment treated with extracorporeal albumin dialysis. Eur J Gastroenterol Hepatol 2005;17:585–8.
  • Arulprakash S, Babu PI, Pugazhendhi T, Jeevankumar S. Benign Recurrent Intrahepatic Cholestasis (BRIC). The internet. J Paediatr Neonatol 2009;9.
  • Crosignani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KD. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism. Hepatology 1991;13:1076–83.
  • Cancado EL, Leitao RM, Carrilho FJ, Laudanna AA. Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpepsidase. Am J Gastroenterol 1998;93:1510–17.
  • Kumagi T, Heathcote EJ. Successfully treated intractable pruritus with rifampicin in a case of benign recurrent intrahepatic cholestasis. Clin J Gastroenterol 2008;1:160–3.
  • Sanderson F, Quaranta JF, Cassuto-Viguier E, Grimaldi C, Troin D, Dujardin P, The value of plasma exchange during flare-ups of benign recurrent intrahepatic cholestasis. Ann Med Interne (Paris) 1988;139:35–7.
  • Bircher J. Correspondence: treatment of patients with Benign Recurrent Intrahepatic Cholestasis. Hepatology 1989;10:1030–3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.